Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Isomerazin
Cat. No.:
0225LY-0751
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Isomerazin displays anti-inflammatory activity by blocking M1 macrophage polarization through the modulation of the ERK, NF-kappaB, and p65 pathways.
Synonym:
1088-17-1; 7-Methoxy-8-(3-methyl-2-oxobutyl)-2H-chromen-2-one; 2H-1-Benzopyran-2-one, 7-methoxy-8-(3-methyl-2-oxobutyl)-; 7-Methoxy-8-(2-oxo-3-methylbutyl) coumarin; 7-Methoxy-8-(3-methyl-2-oxo-butyl)chromen-2-one
CAS No.:
1088-17-1
Compound CID:
473252
Formula:
C15H16O4
Formula Weight:
260.29
Specification
Relative Density:
1.178 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Isomerazin can be used in chemical biology studies to explore the structure and biological activity of novel natural product derivatives.
Library Information
Target:
ERK; NF-κB; AChE
Receptor:
ERK; NF-κB; AChE
Pathways:
NF-κB; MAPK; Neuronal signaling
Plate Number:
AOCL-10
Plate Location:
f8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
60 mg/mL; 230.51 mM
